{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:20:04Z","timestamp":1782512404312,"version":"3.54.5"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s43440-025-00766-x","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T12:13:05Z","timestamp":1753704785000},"page":"102-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting TRPC6 in podocytopathies: Why clinical translation remains a challenge?"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2969-2955","authenticated-orcid":false,"given":"Chirag A.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhirkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmishtha","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayesh","family":"Beladiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Rajesh","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","first-page":"6897390","DOI":"10.1155\/2020\/6897390","volume":"2020","author":"Q Wang","year":"2020","unstructured":"Wang Q, Tian X, Wang Y, Wang Y, Li J, Zhao T, et al. Role of transient receptor potential canonical channel 6 (TRPC6) in diabetic kidney disease by regulating podocyte actin cytoskeleton rearrangement. J Diabetes Res. 2020;2020:6897390. https:\/\/doi.org\/10.1155\/2020\/6897390.","journal-title":"J Diabetes Res"},{"key":"766_CR2","doi-asserted-by":"publisher","first-page":"F393","DOI":"10.1152\/ajprenal.00186.2015","volume":"309","author":"DV Ilatovskaya","year":"2015","unstructured":"Ilatovskaya DV, Staruschenko A. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases. Am J Physiol Physiol. 2015;309:F393\u20137. https:\/\/doi.org\/10.1152\/ajprenal.00186.2015.","journal-title":"Am J Physiol Physiol"},{"key":"766_CR3","doi-asserted-by":"publisher","unstructured":"Yu SM-W, Nissaisorakarn P, Husain I, Jim B. Proteinuric kidney diseases: A podocyte\u2019s Slit diaphragm and cytoskeleton approach. Front Med 2018;5. https:\/\/doi.org\/10.3389\/fmed.2018.00221","DOI":"10.3389\/fmed.2018.00221"},{"key":"766_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1152\/physrev.00013.2022","volume":"103","author":"A Staruschenko","year":"2023","unstructured":"Staruschenko A, Ma R, Palygin O, Dryer SE. Ion channels and channelopathies in glomeruli. Physiol Rev. 2023;103:787\u2013854. https:\/\/doi.org\/10.1152\/physrev.00013.2022.","journal-title":"Physiol Rev"},{"key":"766_CR5","doi-asserted-by":"publisher","first-page":"652059","DOI":"10.1155\/2012\/652059","volume":"2012","author":"S Yu","year":"2012","unstructured":"Yu S, Yu L. Dexamethasone resisted podocyte injury via stabilizing TRPC6 expression and distribution. Evid Based Complement Alternat Med. 2012;2012:652059. https:\/\/doi.org\/10.1155\/2012\/652059.","journal-title":"Evid Based Complement Alternat Med"},{"key":"766_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10157-020-01854-3","volume":"24","author":"H Kawachi","year":"2020","unstructured":"Kawachi H, Fukusumi Y. New insight into podocyte Slit diaphragm, a therapeutic target of proteinuria. Clin Exp Nephrol. 2020;24:193\u2013204. https:\/\/doi.org\/10.1007\/s10157-020-01854-3.","journal-title":"Clin Exp Nephrol"},{"key":"766_CR7","doi-asserted-by":"publisher","unstructured":"Hall G, Wang L, Spurney RF. TRPC channels in proteinuric kidney diseases. Cells. 2020;9. https:\/\/doi.org\/10.3390\/cells9010044.","DOI":"10.3390\/cells9010044"},{"key":"766_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.14715\/cmb\/2024.70.5.42","volume":"70","author":"M Yu","year":"2024","unstructured":"Yu M, Hu J, Ju T, Wang R, Wang M, Gao C, et al. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury. Cell Mol Biol (Noisy-Le-Grand). 2024;70:284\u20138. https:\/\/doi.org\/10.14715\/cmb\/2024.70.5.42.","journal-title":"Cell Mol Biol (Noisy-Le-Grand)"},{"key":"766_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-3-642-54215-2_7","volume":"222","author":"A Dietrich","year":"2014","unstructured":"Dietrich A, Gudermann T. TRPC6: physiological function and pathophysiological relevance. Handb Exp Pharmacol. 2014;222:157\u201388. https:\/\/doi.org\/10.1007\/978-3-642-54215-2_7.","journal-title":"Handb Exp Pharmacol"},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/ng1592","volume":"37","author":"J Reiser","year":"2005","unstructured":"Reiser J, Polu KR, M\u00f6ller CC, Kenlan P, Altintas MM, Wei C, et al. TRPC6 is a glomerular Slit diaphragm-associated channel required for normal renal function. Nat Genet. 2005;37:739\u201344. https:\/\/doi.org\/10.1038\/ng1592.","journal-title":"Nat Genet"},{"key":"766_CR11","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.1038\/sj.emboj.7601417","volume":"25","author":"N Onohara","year":"2006","unstructured":"Onohara N, Nishida M, Inoue R, Kobayashi H, Sumimoto H, Sato Y, et al. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J. 2006;25:5305\u201316. https:\/\/doi.org\/10.1038\/sj.emboj.7601417.","journal-title":"EMBO J"},{"key":"766_CR12","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1073\/pnas.1308963111","volume":"111","author":"K Seo","year":"2014","unstructured":"Seo K, Rainer PP, Shalkey Hahn V, Lee D-I, Jo S-H, Andersen A, et al. Combined TRPC3 and TRPC6 Blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy. Proc Natl Acad Sci U S A. 2014;111:1551\u20136. https:\/\/doi.org\/10.1073\/pnas.1308963111.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"766_CR13","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/CIRCRESAHA.114.302614","volume":"114","author":"K Seo","year":"2014","unstructured":"Seo K, Rainer PP, Lee D-I, Hao S, Bedja D, Birnbaumer L, et al. Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation. Circ Res. 2014;114:823\u201332. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302614.","journal-title":"Circ Res"},{"key":"766_CR14","doi-asserted-by":"publisher","unstructured":"Lin BL, Shin JY, Jeffreys WP, Wang N, Lukban CA, Moorer MC, et al. Pharmacological TRPC6 Inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy. JCI Insight. 2022;7. https:\/\/doi.org\/10.1172\/jci.insight.158906.","DOI":"10.1172\/jci.insight.158906"},{"key":"766_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.devcel.2012.08.017","volume":"23","author":"J Davis","year":"2012","unstructured":"Davis J, Burr AR, Davis GF, Birnbaumer L, Molkentin JD. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev Cell. 2012;23:705\u201315. https:\/\/doi.org\/10.1016\/j.devcel.2012.08.017.","journal-title":"Dev Cell"},{"key":"766_CR16","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1242\/jcs.147314","volume":"127","author":"H Takada","year":"2014","unstructured":"Takada H, Furuya K, Sokabe M. Mechanosensitive ATP release from hemichannels and Ca2+ influx through TRPC6 accelerate wound closure in keratinocytes. J Cell Sci. 2014;127:4159\u201371. https:\/\/doi.org\/10.1242\/jcs.147314.","journal-title":"J Cell Sci"},{"key":"766_CR17","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1113\/JP280950","volume":"599","author":"OF Harraz","year":"2021","unstructured":"Harraz OF, Jensen LJ. Vascular calcium signalling and ageing. J Physiol. 2021;599:5361\u201377. https:\/\/doi.org\/10.1113\/JP280950.","journal-title":"J Physiol"},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1084\/jem.20111355","volume":"209","author":"M Tauseef","year":"2012","unstructured":"Tauseef M, Knezevic N, Chava KR, Smith M, Sukriti S, Gianaris N, et al. TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation. J Exp Med. 2012;209:1953\u201368. https:\/\/doi.org\/10.1084\/jem.20111355.","journal-title":"J Exp Med"},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"19093","DOI":"10.1073\/pnas.0606728103","volume":"103","author":"N Weissmann","year":"2006","unstructured":"Weissmann N, Dietrich A, Fuchs B, Kalwa H, Ay M, Dumitrascu R, et al. Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci U S A. 2006;103:19093\u20138. https:\/\/doi.org\/10.1073\/pnas.0606728103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"766_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jneuroim.2018.10.010","volume":"325","author":"GA Ramirez","year":"2018","unstructured":"Ramirez GA, Coletto LA, Bozzolo EP, Citterio L, Delli Carpini S, Zagato L, et al. The TRPC6 intronic polymorphism, associated with the risk of neurological disorders in systemic lupus erythematous, influences immune cell function. J Neuroimmunol. 2018;325:43\u201353. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.10.010.","journal-title":"J Neuroimmunol"},{"key":"766_CR21","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1074\/jbc.M308478200","volume":"279","author":"X Chu","year":"2004","unstructured":"Chu X, Tong Q, Cheung JY, Wozney J, Conrad K, Mazack V, et al. Interaction of TRPC2 and TRPC6 in erythropoietin modulation of calcium Influx *. J Biol Chem. 2004;279:10514\u201322. https:\/\/doi.org\/10.1074\/jbc.M308478200.","journal-title":"J Biol Chem"},{"key":"766_CR22","doi-asserted-by":"publisher","first-page":"17517","DOI":"10.1074\/jbc.275.23.17517","volume":"275","author":"M Schaefer","year":"2000","unstructured":"Schaefer M, Plant TD, Obukhov AG, Hofmann T, Gudermann T, Schultz G. Receptor-mediated regulation of the nonselective cation channels TRPC4 and TRPC5. J Biol Chem. 2000;275:17517\u201326. https:\/\/doi.org\/10.1074\/jbc.275.23.17517.","journal-title":"J Biol Chem"},{"key":"766_CR23","doi-asserted-by":"publisher","first-page":"15223","DOI":"10.1074\/jbc.M312076200","volume":"279","author":"T Voets","year":"2004","unstructured":"Voets T, Janssens A, Droogmans G, Nilius B. Outer pore architecture of a Ca2+-selective TRP channel. J Biol Chem. 2004;279:15223\u201330. https:\/\/doi.org\/10.1074\/jbc.M312076200.","journal-title":"J Biol Chem"},{"key":"766_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41422-018-0038-2","volume":"28","author":"Q Tang","year":"2018","unstructured":"Tang Q, Guo W, Zheng L, Wu J-X, Liu M, Zhou X, et al. Structure of the receptor-activated human TRPC6 and TRPC3 ion channels. Cell Res. 2018;28:746\u201355. https:\/\/doi.org\/10.1038\/s41422-018-0038-2.","journal-title":"Cell Res"},{"key":"766_CR25","doi-asserted-by":"publisher","first-page":"12655","DOI":"10.1074\/jbc.RA119.008299","volume":"294","author":"BE Talbot","year":"2019","unstructured":"Talbot BE, Vandorpe DH, Stotter BR, Alper SL, Schlondorff JS. Transmembrane insertases and N-glycosylation critically determine synthesis, trafficking, and activity of the nonselective cation channel TRPC6. J Biol Chem. 2019;294:12655\u201369. https:\/\/doi.org\/10.1074\/jbc.RA119.008299.","journal-title":"J Biol Chem"},{"key":"766_CR26","doi-asserted-by":"publisher","first-page":"12242","DOI":"10.1074\/jbc.M312456200","volume":"279","author":"Y Dohke","year":"2004","unstructured":"Dohke Y, Oh YS, Ambudkar IS, Turner RJ. Biogenesis and topology of the transient receptor potential Ca2\u2009+\u2009channel TRPC1. J Biol Chem. 2004;279:12242\u20138. https:\/\/doi.org\/10.1074\/jbc.M312456200.","journal-title":"J Biol Chem"},{"key":"766_CR27","doi-asserted-by":"publisher","first-page":"47842","DOI":"10.1074\/jbc.M302983200","volume":"278","author":"A Dietrich","year":"2003","unstructured":"Dietrich A, Mederos y Schnitzler M, Emmel J, Kalwa H, Hofmann T, Gudermann T. N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity. J Biol Chem. 2003;278:47842\u201352. https:\/\/doi.org\/10.1074\/jbc.M302983200.","journal-title":"J Biol Chem"},{"key":"766_CR28","doi-asserted-by":"publisher","first-page":"13588","DOI":"10.1074\/jbc.M512205200","volume":"281","author":"M Poteser","year":"2006","unstructured":"Poteser M, Graziani A, Rosker C, Eder P, Derler I, Kahr H, et al. TRPC3 and TRPC4 associate to form a redox-sensitive cation channel. Evidence for expression of native TRPC3-TRPC4 heteromeric channels in endothelial cells. J Biol Chem. 2006;281:13588\u201395. https:\/\/doi.org\/10.1074\/jbc.M512205200.","journal-title":"J Biol Chem"},{"key":"766_CR29","doi-asserted-by":"publisher","first-page":"32540","DOI":"10.1074\/jbc.M602496200","volume":"281","author":"JY Kim","year":"2006","unstructured":"Kim JY, Zeng W, Kiselyov K, Yuan JP, Dehoff MH, Mikoshiba K, et al. Homer 1 mediates store- and inositol 1,4,5-trisphosphate receptor-dependent translocation and retrieval of TRPC3 to the plasma membrane. J Biol Chem. 2006;281:32540\u20139. https:\/\/doi.org\/10.1074\/jbc.M602496200.","journal-title":"J Biol Chem"},{"key":"766_CR30","doi-asserted-by":"publisher","first-page":"2376929","DOI":"10.1080\/0886022X.2024.2376929","volume":"46","author":"A Sheng","year":"2024","unstructured":"Sheng A, Liu F, Wang Q, Fu H, Mao J. The roles of TRPC6 in renal tubular disorders: a narrative review. Ren Fail. 2024;46:2376929. https:\/\/doi.org\/10.1080\/0886022X.2024.2376929.","journal-title":"Ren Fail"},{"key":"766_CR31","doi-asserted-by":"publisher","first-page":"22047","DOI":"10.1074\/jbc.M402320200","volume":"279","author":"M Estacion","year":"2004","unstructured":"Estacion M, Li S, Sinkins WG, Gosling M, Bahra P, Poll C, et al. Activation of human TRPC6 channels by receptor stimulation. J Biol Chem. 2004;279:22047\u201356. https:\/\/doi.org\/10.1074\/jbc.M402320200.","journal-title":"J Biol Chem"},{"key":"766_CR32","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0006-291x(84)90270-5","volume":"123","author":"D de Chaffoy","year":"1984","unstructured":"de Chaffoy D, Roevens P, Van Belle H. 1-Oleoyl-2-acetyl-glycerol (OAG) stimulates the formation of phosphatidylinositol 4-phosphate in intact human platelets. Biochem Biophys Res Commun. 1984;123:589\u201395. https:\/\/doi.org\/10.1016\/0006-291x(84)90270-5.","journal-title":"Biochem Biophys Res Commun"},{"key":"766_CR33","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bbadis.2019.04.001","volume":"1865","author":"SE Dryer","year":"2019","unstructured":"Dryer SE, Roshanravan H, Kim EY. TRPC channels: regulation, dysregulation and contributions to chronic kidney disease. Biochim Biophys Acta - Mol Basis Dis. 2019;1865:1041\u201366. https:\/\/doi.org\/10.1016\/j.bbadis.2019.04.001.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"766_CR34","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1113\/jphysiol.2013.251249","volume":"591","author":"J Shi","year":"2013","unstructured":"Shi J, Geshi N, Takahashi S, Kiyonaka S, Ichikawa J, Hu Y, et al. Molecular determinants for cardiovascular TRPC6 channel regulation by Ca2+\/calmodulin-dependent kinase II. J Physiol. 2013;591:2851\u201366. https:\/\/doi.org\/10.1113\/jphysiol.2013.251249.","journal-title":"J Physiol"},{"key":"766_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1113\/jphysiol.2004.075051","volume":"561","author":"J Shi","year":"2004","unstructured":"Shi J, Mori E, Mori Y, Mori M, Li J, Ito Y, et al. Multiple regulation by calcium of murine homologues of transient receptor potential proteins TRPC6 and TRPC7 expressed in HEK293 cells. J Physiol. 2004;561:415\u201332. https:\/\/doi.org\/10.1113\/jphysiol.2004.075051.","journal-title":"J Physiol"},{"key":"766_CR36","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1681\/ASN.2018030280","volume":"29","author":"DV Ilatovskaya","year":"2018","unstructured":"Ilatovskaya DV, Blass G, Palygin O, Levchenko V, Pavlov TS, Grzybowski MN, et al. A NOX4\/TRPC6 pathway in podocyte calcium regulation and renal damage in diabetic kidney disease. J Am Soc Nephrol. 2018;29:1917\u201327. https:\/\/doi.org\/10.1681\/ASN.2018030280.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/jcp.24461","volume":"229","author":"M Anderson","year":"2014","unstructured":"Anderson M, Roshanravan H, Khine J, Dryer SE. Angiotensin II activation of TRPC6 channels in rat podocytes requires generation of reactive oxygen species. J Cell Physiol. 2014;229:434\u201342. https:\/\/doi.org\/10.1002\/jcp.24461.","journal-title":"J Cell Physiol"},{"key":"766_CR38","doi-asserted-by":"publisher","first-page":"F1088","DOI":"10.1152\/ajprenal.00661.2013","volume":"306","author":"H Roshanravan","year":"2014","unstructured":"Roshanravan H, Dryer SE. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of Podocin and reactive oxygen species. Am J Physiol Ren Physiol. 2014;306:F1088\u201397. https:\/\/doi.org\/10.1152\/ajprenal.00661.2013.","journal-title":"Am J Physiol Ren Physiol"},{"key":"766_CR39","doi-asserted-by":"publisher","first-page":"C960","DOI":"10.1152\/ajpcell.00191.2013","volume":"305","author":"EY Kim","year":"2013","unstructured":"Kim EY, Anderson M, Wilson C, Hagmann H, Benzing T, Dryer SE. NOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: essential role of Podocin in formation of this complex. Am J Physiol Cell Physiol. 2013;305:C960\u201371. https:\/\/doi.org\/10.1152\/ajpcell.00191.2013.","journal-title":"Am J Physiol Cell Physiol"},{"key":"766_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s43054-022-00117-y","volume":"70","author":"PA Le Thy","year":"2022","unstructured":"Le Thy PA, Hoang Thi TY, Tran KH, Nguyen HS. Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review. Egypt Pediatr Assoc Gaz. 2022;70:24. https:\/\/doi.org\/10.1186\/s43054-022-00117-y.","journal-title":"Egypt Pediatr Assoc Gaz"},{"key":"766_CR41","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1016\/j.bbadis.2018.08.007","volume":"1864","author":"EY Kim","year":"2018","unstructured":"Kim EY, Hassanzadeh Khayyat N, Dryer SE. Mechanisms underlying modulation of podocyte TRPC6 channels by supar: role of NADPH oxidases and Src family tyrosine kinases. Biochim Biophys Acta Mol Basis Dis. 2018;1864:3527\u201336. https:\/\/doi.org\/10.1016\/j.bbadis.2018.08.007.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"766_CR42","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1016\/j.bbamcr.2015.07.011","volume":"1853","author":"EY Kim","year":"2015","unstructured":"Kim EY, Roshanravan H, Dryer SE. Syndecan-4 ectodomain evokes mobilization of podocyte TRPC6 channels and their associated pathways: an essential role for integrin signaling. Biochim Biophys Acta - Mol Cell Res. 2015;1853:2610\u201320. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.07.011.","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"766_CR43","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.bbadis.2017.06.010","volume":"1863","author":"EY Kim","year":"2017","unstructured":"Kim EY, Roshanravan H, Dryer SE. Changes in podocyte TRPC channels evoked by plasma and Sera from patients with recurrent FSGS and by putative glomerular permeability factors. Biochim Biophys Acta - Mol Basis Dis. 2017;1863:2342\u201354. https:\/\/doi.org\/10.1016\/j.bbadis.2017.06.010.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"766_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.bbrc.2015.04.054","volume":"461","author":"B Zhao","year":"2015","unstructured":"Zhao B, Yang H, Zhang R, Sun H, Liao C, Xu J, et al. The role of TRPC6 in oxidative stress-induced podocyte ischemic injury. Biochem Biophys Res Commun. 2015;461:413\u201320. https:\/\/doi.org\/10.1016\/j.bbrc.2015.04.054.","journal-title":"Biochem Biophys Res Commun"},{"key":"766_CR45","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/01.res.88.3.325","volume":"88","author":"R Inoue","year":"2001","unstructured":"Inoue R, Okada T, Onoue H, Hara Y, Shimizu S, Naitoh S, et al. The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca(2+)-permeable cation channel. Circ Res. 2001;88:325\u201332. https:\/\/doi.org\/10.1161\/01.res.88.3.325.","journal-title":"Circ Res"},{"key":"766_CR46","doi-asserted-by":"publisher","first-page":"17079","DOI":"10.1073\/pnas.0607465103","volume":"103","author":"TB Huber","year":"2006","unstructured":"Huber TB, Schermer B, M\u00fcller RU, H\u00f6hne M, Bartram M, Calixto A, et al. Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci U S A. 2006;103:17079\u201386. https:\/\/doi.org\/10.1073\/pnas.0607465103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"766_CR47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.semnephrol.2012.06.004","volume":"32","author":"N Endlich","year":"2012","unstructured":"Endlich N, Endlich K. The challenge and response of podocytes to glomerular hypertension. Semin Nephrol. 2012;32:327\u201341. https:\/\/doi.org\/10.1016\/j.semnephrol.2012.06.004.","journal-title":"Semin Nephrol"},{"key":"766_CR48","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.kint.2017.02.032","volume":"91","author":"W Kriz","year":"2017","unstructured":"Kriz W, Lemley KV. Potential relevance of shear stress for Slit diaphragm and podocyte function. Kidney Int. 2017;91:1283\u20136. https:\/\/doi.org\/10.1016\/j.kint.2017.02.032.","journal-title":"Kidney Int"},{"key":"766_CR49","doi-asserted-by":"publisher","first-page":"29031","DOI":"10.1074\/jbc.M302751200","volume":"278","author":"K Venkatachalam","year":"2003","unstructured":"Venkatachalam K, Zheng F, Gill DL. Regulation of canonical transient receptor potential (TRPC) channel function by Diacylglycerol and protein kinase C*. J Biol Chem. 2003;278:29031\u201340. https:\/\/doi.org\/10.1074\/jbc.M302751200.","journal-title":"J Biol Chem"},{"key":"766_CR50","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbamcr.2008.11.001","volume":"1793","author":"GM Salido","year":"2009","unstructured":"Salido GM, Sage SO, Rosado JA. TRPC channels and store-operated Ca2\u2009+\u2009entry. Biochim Biophys Acta - Mol Cell Res. 2009;1793:223\u201330. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.11.001. https:\/\/doi.org\/https:\/\/doi.org\/.","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"766_CR51","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1681\/ASN.2009121253","volume":"21","author":"Y Wang","year":"2010","unstructured":"Wang Y, Jarad G, Tripathi P, Pan M, Cunningham J, Martin DR, et al. Activation of NFAT signaling in podocytes causes glomerulosclerosis. J Am Soc Nephrol. 2010;21:1657\u201366. https:\/\/doi.org\/10.1681\/ASN.2009121253.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR52","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.molcel.2017.05.028","volume":"66","author":"R Bagur","year":"2017","unstructured":"Bagur R, Hajn\u00f3czky G. Intracellular Ca(2+) sensing: its role in calcium homeostasis and signaling. Mol Cell. 2017;66:780\u20138. https:\/\/doi.org\/10.1016\/j.molcel.2017.05.028.","journal-title":"Mol Cell"},{"key":"766_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jjcc.2023.04.017","volume":"83","author":"P Zhang","year":"2024","unstructured":"Zhang P, Huang C, Liu H, Zhang M, Liu L, Zhai Y, et al. The mechanism of the NFAT transcription factor family involved in oxidative stress response. J Cardiol. 2024;83:30\u20136. https:\/\/doi.org\/10.1016\/j.jjcc.2023.04.017.","journal-title":"J Cardiol"},{"key":"766_CR54","doi-asserted-by":"publisher","unstructured":"Tong L, Tergaonkar V. Rho protein GTPases and their interactions with NF\u03baB: crossroads of inflammation and matrix biology. Biosci Rep. 2014;34. https:\/\/doi.org\/10.1042\/BSR20140021.","DOI":"10.1042\/BSR20140021"},{"key":"766_CR55","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jhep.2020.09.035","volume":"74","author":"S-Y Cai","year":"2021","unstructured":"Cai S-Y, Yu D, Soroka CJ, Wang J, Boyer JL. Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis. J Hepatol. 2021;74:550\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2020.09.035.","journal-title":"J Hepatol"},{"key":"766_CR56","doi-asserted-by":"publisher","first-page":"e2199","DOI":"10.1038\/cddis.2016.97","volume":"7","author":"GP Mognol","year":"2016","unstructured":"Mognol GP, Carneiro FRG, Robbs BK, Faget DV, Viola JPB. Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player. Cell Death Dis. 2016;7:e2199. https:\/\/doi.org\/10.1038\/cddis.2016.97.","journal-title":"Cell Death Dis"},{"key":"766_CR57","doi-asserted-by":"publisher","first-page":"18407","DOI":"10.1074\/jbc.M113.463059","volume":"288","author":"D Chiluiza","year":"2013","unstructured":"Chiluiza D, Krishna S, Schumacher VA, Schl\u00f6ndorff J. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular Signal-regulated kinases 1\/2 (ERK1\/2)*. J Biol Chem. 2013;288:18407\u201320. https:\/\/doi.org\/10.1074\/jbc.M113.463059.","journal-title":"J Biol Chem"},{"key":"766_CR58","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/DDDT.S234262","volume":"14","author":"J Yu","year":"2020","unstructured":"Yu J, Zhu C, Yin J, Yu D, Wan F, Tang X, et al. Tetrandrine suppresses transient receptor potential cation channel protein 6 Overexpression- induced podocyte damage via blockage of RhoA\/ROCK1 signaling. Drug Des Devel Ther. 2020;14:361\u201370. https:\/\/doi.org\/10.2147\/DDDT.S234262.","journal-title":"Drug Des Devel Ther"},{"key":"766_CR59","doi-asserted-by":"publisher","first-page":"14080","DOI":"10.1074\/jbc.M117.777896","volume":"292","author":"NK Singh","year":"2017","unstructured":"Singh NK, Janjanam J, Rao GN. p115 RhoGEF activates the Rac1 GTPase signaling cascade in MCP1 chemokine-induced vascular smooth muscle cell migration and proliferation. J Biol Chem. 2017;292:14080\u201391. https:\/\/doi.org\/10.1074\/jbc.M117.777896.","journal-title":"J Biol Chem"},{"key":"766_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1476-5381.2009.00121.x","volume":"158","author":"S Siehler","year":"2009","unstructured":"Siehler S. Regulation of RhoGEF proteins by G12\/13-coupled receptors. Br J Pharmacol. 2009;158:41\u20139. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00121.x.","journal-title":"Br J Pharmacol"},{"key":"766_CR61","doi-asserted-by":"publisher","unstructured":"Guan G, Cannon RD, Coates DE, Mei L. Effect of the Rho-Kinase\/ROCK signaling pathway on cytoskeleton components. Genes (Basel). 2023;14. https:\/\/doi.org\/10.3390\/genes14020272.","DOI":"10.3390\/genes14020272"},{"key":"766_CR62","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/CIRCRESAHA.108.188524","volume":"104","author":"Y Wang","year":"2009","unstructured":"Wang Y, Zheng XR, Riddick N, Bryden M, Baur W, Zhang X, et al. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ Res. 2009;104:531\u201340. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.188524.","journal-title":"Circ Res"},{"key":"766_CR63","doi-asserted-by":"publisher","first-page":"113920","DOI":"10.1016\/j.biopha.2022.113920","volume":"156","author":"E Ahmadian","year":"2022","unstructured":"Ahmadian E, Eftekhari A, Atakishizada S, Valiyeva M, Ardalan M, Khalilov R, et al. Podocytopathy: the role of actin cytoskeleton. Biomed Pharmacother. 2022;156:113920. https:\/\/doi.org\/10.1016\/j.biopha.2022.113920.","journal-title":"Biomed Pharmacother"},{"key":"766_CR64","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1021\/bi9718447","volume":"37","author":"B Zhang","year":"1998","unstructured":"Zhang B, Zheng Y. Regulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, bcr, and 3BP-1. Biochemistry. 1998;37:5249\u201357. https:\/\/doi.org\/10.1021\/bi9718447.","journal-title":"Biochemistry"},{"key":"766_CR65","doi-asserted-by":"publisher","unstructured":"Amemiya Y, Maki M, Shibata H, Takahara T. New insights into the regulation of mTOR signaling via Ca2+-Binding proteins. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms24043923.","DOI":"10.3390\/ijms24043923"},{"key":"766_CR66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"766_CR67","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274\u201393. https:\/\/doi.org\/10.1016\/j.cell.2012.03.017.","journal-title":"Cell"},{"key":"766_CR68","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1172\/JCI44774","volume":"121","author":"M G\u00f6del","year":"2011","unstructured":"G\u00f6del M, Hartleben B, Herbach N, Liu S, Zschiedrich S, Lu S, et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest. 2011;121:2197\u2013209. https:\/\/doi.org\/10.1172\/JCI44774.","journal-title":"J Clin Invest"},{"key":"766_CR69","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1681\/ASN.2016111248","volume":"29","author":"KAT Verheijden","year":"2018","unstructured":"Verheijden KAT, Sonneveld R, Bakker-van Bebber M, Wetzels JFM, van der Vlag J, Nijenhuis T. The Calcium-Dependent protease Calpain-1 links TRPC6 activity to podocyte injury. J Am Soc Nephrol. 2018;29:2099\u2013109. https:\/\/doi.org\/10.1681\/ASN.2016111248.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR70","doi-asserted-by":"publisher","unstructured":"Tian X, Inoue K, Zhang Y, Wang Y, Sperati CJ, Pedigo CE, et al. Inhibiting Calpain 1 and 2 in Cyclin G associated kinase-knockout mice mitigates podocyte injury. JCI Insight. 2020;5. https:\/\/doi.org\/10.1172\/jci.insight.142740.","DOI":"10.1172\/jci.insight.142740"},{"key":"766_CR71","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.kint.2021.02.024","volume":"100","author":"I Bensaada","year":"2021","unstructured":"Bensaada I, Robin B, Perez J, Salemkour Y, Chipont A, Camus M, et al. Calpastatin prevents angiotensin II-mediated podocyte injury through maintenance of autophagy. Kidney Int. 2021;100:90\u2013106. https:\/\/doi.org\/10.1016\/j.kint.2021.02.024.","journal-title":"Kidney Int"},{"key":"766_CR72","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fendo.2018.00302","volume":"9","author":"CE Martin","year":"2018","unstructured":"Martin CE, Jones N. Nephrin signaling in the podocyte: an updated view of signal regulation at the Slit diaphragm and beyond. Front Endocrinol (Lausanne). 2018;9:302. https:\/\/doi.org\/10.3389\/fendo.2018.00302.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"766_CR73","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0960-9822(01)00560-7","volume":"11","author":"RE Palmer","year":"2001","unstructured":"Palmer RE, Kotsianti A, Cadman B, Boyd T, Gerald W, Haber DA. WT1 regulates the expression of the major glomerular podocyte membrane protein podocalyxin. Curr Biol. 2001;11:1805\u20139. https:\/\/doi.org\/10.1016\/S0960-9822(01)00560-7.","journal-title":"Curr Biol"},{"key":"766_CR74","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.kint.2016.09.001","volume":"91","author":"W Shoda","year":"2017","unstructured":"Shoda W, Nomura N, Ando F, Mori Y, Mori T, Sohara E, et al. Calcineurin inhibitors block sodium-chloride cotransporter dephosphorylation in response to high potassium intake. Kidney Int. 2017;91:402\u201311. https:\/\/doi.org\/10.1016\/j.kint.2016.09.001.","journal-title":"Kidney Int"},{"key":"766_CR75","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1097\/01.ASN.0000146689.88078.80","volume":"15","author":"H Li","year":"2004","unstructured":"Li H, Lemay S, Aoudjit L, Kawachi H, Takano T. SRC-family kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with Podocin. J Am Soc Nephrol. 2004;15:3006\u201315. https:\/\/doi.org\/10.1097\/01.ASN.0000146689.88078.80.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR76","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0002-9440(10)64421-5","volume":"161","author":"MA Saleem","year":"2002","unstructured":"Saleem MA, Ni L, Witherden I, Tryggvason K, Ruotsalainen V, Mundel P, et al. Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation. Am J Pathol. 2002;161:1459\u201366. https:\/\/doi.org\/10.1016\/S0002-9440(10)64421-5.","journal-title":"Am J Pathol"},{"key":"766_CR77","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","volume":"89","author":"M Nagata","year":"2016","unstructured":"Nagata M. Podocyte injury and its consequences. Kidney Int. 2016;89:1221\u201330. https:\/\/doi.org\/10.1016\/j.kint.2016.01.012.","journal-title":"Kidney Int"},{"key":"766_CR78","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000634","author":"W Li","year":"2025","unstructured":"Li W, Zhang Z, Peng Z, Hu H, Cui X, Zhu Z, et al. PIEZO1-Mediated calcium signaling and podocyte injury in diabetic kidney disease. J Am Soc Nephrol. 2025. https:\/\/doi.org\/10.1681\/ASN.0000000634.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR79","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.gendis.2021.03.002","volume":"9","author":"L Chen","year":"2022","unstructured":"Chen L, Song M, Yao C. Calcineurin in development and disease. Genes Dis. 2022;9:915\u201327. https:\/\/doi.org\/10.1016\/j.gendis.2021.03.002. https:\/\/doi.org\/https:\/\/doi.org\/.","journal-title":"Genes Dis"},{"key":"766_CR80","doi-asserted-by":"publisher","first-page":"8832114","DOI":"10.1155\/2021\/8832114","volume":"2021","author":"R Ma","year":"2021","unstructured":"Ma R, Wang Y, Xu Y, Wang R, Wang X, Yu N, et al. Tacrolimus protects podocytes from apoptosis via downregulation of TRPC6 in diabetic nephropathy. J Diabetes Res. 2021;2021:8832114. https:\/\/doi.org\/10.1155\/2021\/8832114.","journal-title":"J Diabetes Res"},{"key":"766_CR81","doi-asserted-by":"publisher","unstructured":"Lee H, Myoung H, Kim SM. Review of two immunosuppressants: tacrolimus and cyclosporine. J Korean Assoc Oral Maxillofac Surg. 2023;49. https:\/\/doi.org\/10.5125\/jkaoms.2023.49.6.311.:311\u2013\u200923.","DOI":"10.5125\/jkaoms.2023.49.6.311"},{"key":"766_CR82","doi-asserted-by":"publisher","first-page":"10156","DOI":"10.1073\/pnas.1815354116","volume":"116","author":"BL Lin","year":"2019","unstructured":"Lin BL, Matera D, Doerner JF, Zheng N, Del Camino D, Mishra S, et al. In vivo selective Inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease. Proc Natl Acad Sci U S A. 2019;116:10156\u201361. https:\/\/doi.org\/10.1073\/pnas.1815354116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"766_CR83","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1016\/j.ekir.2023.09.026","volume":"8","author":"H Trachtman","year":"2023","unstructured":"Trachtman H, Kretzler M, Desmond HE, Choi W, Manuel RC, Soleymanlou N. TRPC6 inhibitor BI 764198 in focal segmental glomerulosclerosis: phase 2 study design. Kidney Int Rep. 2023;8:2822\u20135. https:\/\/doi.org\/10.1016\/j.ekir.2023.09.026.","journal-title":"Kidney Int Rep"},{"key":"766_CR84","doi-asserted-by":"publisher","unstructured":"Blaine J, Dylewski J. Regulation of the actin cytoskeleton in podocytes. Cells. 2020;9. https:\/\/doi.org\/10.3390\/cells9071700.","DOI":"10.3390\/cells9071700"},{"key":"766_CR85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1053\/j.gastro.2009.11.016","volume":"138","author":"S Rattan","year":"2010","unstructured":"Rattan S, Phillips BR, Maxwell PJ 4. th. RhoA\/Rho-kinase: pathophysiologic and therapeutic implications in Gastrointestinal smooth muscle tone and relaxation. Gastroenterology. 2010;138:13. https:\/\/doi.org\/10.1053\/j.gastro.2009.11.016.","journal-title":"Gastroenterology"},{"key":"766_CR86","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cm.20472","volume":"67","author":"M Amano","year":"2010","unstructured":"Amano M, Nakayama M, Kaibuchi K. Rho-kinase\/ROCK: A key regulator of the cytoskeleton and cell Polarity. Cytoskeleton (Hoboken). 2010;67:545\u201354. https:\/\/doi.org\/10.1002\/cm.20472.","journal-title":"Cytoskeleton (Hoboken)"},{"key":"766_CR87","first-page":"4296","volume":"11","author":"Q Yan","year":"2018","unstructured":"Yan Q, Wang X, Zha M, Yu M, Sheng M, Yu J. The rhoa\/rock signaling pathway affects the development of diabetic nephropathy resulting from the epithelial to mesenchymal transition. Int J Clin Exp Pathol. 2018;11:4296\u2013304.","journal-title":"Int J Clin Exp Pathol"},{"key":"766_CR88","doi-asserted-by":"publisher","first-page":"106153","DOI":"10.1016\/j.biocel.2021.106153","volume":"143","author":"YM Teh","year":"2022","unstructured":"Teh YM, Mualif SA, Lim SK. A comprehensive insight into autophagy and its potential signaling pathways as a therapeutic target in podocyte injury. Int J Biochem Cell Biol. 2022;143:106153. https:\/\/doi.org\/10.1016\/j.biocel.2021.106153.","journal-title":"Int J Biochem Cell Biol"},{"key":"766_CR89","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1681\/ASN.0000000000000212","volume":"34","author":"Y Salemkour","year":"2023","unstructured":"Salemkour Y, Yildiz D, Dionet L, \u2019t Hart DC, Verheijden KAT, Saito R, et al. Podocyte injury in diabetic kidney disease in mouse models involves TRPC6-mediated Calpain activation impairing autophagy. J Am Soc Nephrol. 2023;34:1823\u201342. https:\/\/doi.org\/10.1681\/ASN.0000000000000212.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR90","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000121531","volume":"31","author":"L Wang","year":"2008","unstructured":"Wang L, Ellis MJ, Fields TA, Howell DN, Spurney RF. Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis. Kidney Blood Press Res. 2008;31:111\u201321. https:\/\/doi.org\/10.1159\/000121531.","journal-title":"Kidney Blood Press Res"},{"key":"766_CR91","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00018-009-0189-x","volume":"67","author":"C Hahmann","year":"2010","unstructured":"Hahmann C, Schroeter T. Rho-kinase inhibitors as therapeutics: from Pan Inhibition to isoform selectivity. Cell Mol Life Sci. 2010;67:171\u20137. https:\/\/doi.org\/10.1007\/s00018-009-0189-x.","journal-title":"Cell Mol Life Sci"},{"key":"766_CR92","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1074\/jbc.M112.439463","volume":"288","author":"LA New","year":"2013","unstructured":"New LA, Keyvani Chahi A, Jones N. Direct regulation of nephrin tyrosine phosphorylation by Nck adaptor proteins**. J Biol Chem. 2013;288:1500\u201310. https:\/\/doi.org\/10.1074\/jbc.M112.439463.","journal-title":"J Biol Chem"},{"key":"766_CR93","doi-asserted-by":"publisher","unstructured":"Yasuda-Yamahara M, Kume S, Maegawa H. Roles of mTOR in diabetic kidney disease. Antioxid (Basel Switzerland). 2021;10. https:\/\/doi.org\/10.3390\/antiox10020321.","DOI":"10.3390\/antiox10020321"},{"key":"766_CR94","doi-asserted-by":"publisher","unstructured":"Baffi TR, Lord\u00e9n G, Wozniak JM, Feichtner A, Yeung W, Kornev AP, et al. mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif. Sci Signal. 2021;14. https:\/\/doi.org\/10.1126\/scisignal.abe4509.","DOI":"10.1126\/scisignal.abe4509"},{"key":"766_CR95","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1681\/ASN.2009040379","volume":"20","author":"G Mollet","year":"2009","unstructured":"Mollet G, Ratelade J, Boyer O, Muda AO, Morisset L, Lavin TA, et al. Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome. J Am Soc Nephrol. 2009;20:2181\u20139. https:\/\/doi.org\/10.1681\/ASN.2009040379.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR96","doi-asserted-by":"publisher","unstructured":"Ma MKM, Yung S, Chan TM. mTOR Inhibition and Kidney Diseases. Transplantation. 2018;102:S32-40. https:\/\/doi.org\/10.1097\/TP.0000000000001729","DOI":"10.1097\/TP.0000000000001729"},{"key":"766_CR97","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1007\/s10495-010-0526-4","volume":"15","author":"JA Martinez","year":"2010","unstructured":"Martinez JA, Zhang Z, Svetlov SI, Hayes RL, Wang KK, Larner SF. Calpain and caspase processing of caspase-12 contribute to the ER stress-induced cell death pathway in differentiated PC12 cells. Apoptosis. 2010;15:1480\u201393. https:\/\/doi.org\/10.1007\/s10495-010-0526-4.","journal-title":"Apoptosis"},{"key":"766_CR98","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3892\/br.2016.785","volume":"5","author":"J Ji","year":"2016","unstructured":"Ji J, Su L, Liu Z. Critical role of Calpain in inflammation. Biomed Rep. 2016;5:647\u201352. https:\/\/doi.org\/10.3892\/br.2016.785.","journal-title":"Biomed Rep"},{"key":"766_CR99","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1681\/ASN.2018070729","volume":"30","author":"LK Farmer","year":"2019","unstructured":"Farmer LK, Rollason R, Whitcomb DJ, Ni L, Goodliff A, Lay AC, et al. TRPC6 binds to and activates calpain, independent of its channel activity, and regulates podocyte cytoskeleton, cell adhesion, and motility. J Am Soc Nephrol. 2019;30:1910\u201324. https:\/\/doi.org\/10.1681\/ASN.2018070729.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR100","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12906-021-03469-x","volume":"21","author":"Y Ding","year":"2021","unstructured":"Ding Y, Tang X, Wang Y, Yu D, Zhu C, Yu J. Tetrandrine alleviates podocyte injury via calcium-dependent calpain-1 signaling Blockade. BMC Complement Med Ther. 2021;21:296. https:\/\/doi.org\/10.1186\/s12906-021-03469-x.","journal-title":"BMC Complement Med Ther"},{"key":"766_CR101","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1681\/ASN.2015080885","volume":"28","author":"R Sonneveld","year":"2017","unstructured":"Sonneveld R, Hoenderop JG, Isidori AM, Henique C, Dijkman HB, Berden JH, et al. Sildenafil prevents podocyte injury via PPAR-\u03b3-Mediated TRPC6 Inhibition. J Am Soc Nephrol. 2017;28:1491\u2013505. https:\/\/doi.org\/10.1681\/ASN.2015080885.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR102","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1681\/ASN.2011040370","volume":"22","author":"A Greka","year":"2011","unstructured":"Greka A, Mundel P. Balancing calcium signals through TRPC5 and TRPC6 in podocytes. J Am Soc Nephrol. 2011;22:1969\u201380. https:\/\/doi.org\/10.1681\/ASN.2011040370.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR103","doi-asserted-by":"crossref","unstructured":"Wooden B, Beenken A, Martinelli E, Saida K, Knob AL, Ke J et al. Natural history and clinicopathological associations of TRPC6-Associated podocytopathy. J Am Soc Nephrol 2025;36.","DOI":"10.1681\/ASN.0000000501"},{"key":"766_CR104","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1111\/bph.13151","volume":"172","author":"T Maier","year":"2015","unstructured":"Maier T, Follmann M, Hessler G, Kleemann H-W, Hachtel S, Fuchs B, et al. Discovery and Pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels. Br J Pharmacol. 2015;172:3650\u201360. https:\/\/doi.org\/10.1111\/bph.13151.","journal-title":"Br J Pharmacol"},{"key":"766_CR105","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41419-018-1052-5","volume":"9","author":"X Hou","year":"2018","unstructured":"Hou X, Xiao H, Zhang Y, Zeng X, Huang M, Chen X, et al. Transient receptor potential channel 6 knockdown prevents apoptosis of renal tubular epithelial cells upon oxidative stress via autophagy activation. Cell Death Dis. 2018;9:1015. https:\/\/doi.org\/10.1038\/s41419-018-1052-5.","journal-title":"Cell Death Dis"},{"key":"766_CR106","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.bmcl.2018.03.056","volume":"28","author":"K Motoyama","year":"2018","unstructured":"Motoyama K, Nagata T, Kobayashi J, Nakamura A, Miyoshi N, Kazui M, et al. Discovery of a bicyclo[4.3.0]nonane derivative DS88790512 as a potent, selective, and orally bioavailable blocker of transient receptor potential canonical 6 (TRPC6). Bioorg Med Chem Lett. 2018;28:2222\u20137. https:\/\/doi.org\/10.1016\/j.bmcl.2018.03.056.","journal-title":"Bioorg Med Chem Lett"},{"key":"766_CR107","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1124\/mol.115.100792","volume":"89","author":"N Urban","year":"2016","unstructured":"Urban N, Wang L, Kwiek S, Rademann J, Kuebler WM, Schaefer M. Identification and validation of Larixyl acetate as a potent TRPC6 inhibitor. Mol Pharmacol. 2016;89:197\u2013213. https:\/\/doi.org\/10.1124\/mol.115.100792.","journal-title":"Mol Pharmacol"},{"key":"766_CR108","doi-asserted-by":"publisher","unstructured":"Jia M, Liu W, Zhang K, Wang Z, Li R, Pan J, et al. Larixyl acetate, a TRPC6 inhibitor, attenuates pressure overload\u2013induced heart failure in mice. Mol Med Rep. 2024;29. https:\/\/doi.org\/10.3892\/mmr.2024.13174.","DOI":"10.3892\/mmr.2024.13174"},{"key":"766_CR109","doi-asserted-by":"publisher","first-page":"115091","DOI":"10.1016\/j.bcp.2022.115091","volume":"201","author":"H-R Liao","year":"2022","unstructured":"Liao H-R, Kao Y-Y, Leu Y-L, Liu F-C, Tseng C-P. Larixol inhibits fMLP-induced superoxide anion production and chemotaxis by targeting the \u03b2\u03b3 subunit of Gi-protein of fMLP receptor in human neutrophils. Biochem Pharmacol. 2022;201:115091. https:\/\/doi.org\/10.1016\/j.bcp.2022.115091.","journal-title":"Biochem Pharmacol"},{"key":"766_CR110","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12974-019-1407-6","volume":"16","author":"X Chen","year":"2019","unstructured":"Chen X, Taylor-Nguyen NN, Riley AM, Herring BP, White FA, Obukhov AG. The TRPC6 inhibitor, Larixyl acetate, is effective in protecting against traumatic brain injury-induced systemic endothelial dysfunction. J Neuroinflammation. 2019;16:21. https:\/\/doi.org\/10.1186\/s12974-019-1407-6.","journal-title":"J Neuroinflammation"},{"key":"766_CR111","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12974-020-01767-8","volume":"17","author":"J Wang","year":"2020","unstructured":"Wang J, Zhao M, Jia P, Liu F-F, Chen K, Meng F-Y, et al. The analgesic action of Larixyl acetate, a potent TRPC6 inhibitor, in rat neuropathic pain model induced by spared nerve injury. J Neuroinflammation. 2020;17:118. https:\/\/doi.org\/10.1186\/s12974-020-01767-8.","journal-title":"J Neuroinflammation"},{"key":"766_CR112","doi-asserted-by":"publisher","first-page":"10997","DOI":"10.1074\/jbc.M411797200","volume":"280","author":"L-P He","year":"2005","unstructured":"He L-P, Hewavitharana T, Soboloff J, Spassova MA, Gill DL. A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl)pyrazole derivative, BTP2. J Biol Chem. 2005;280:10997\u20131006. https:\/\/doi.org\/10.1074\/jbc.M411797200.","journal-title":"J Biol Chem"},{"key":"766_CR113","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1042\/bj2710515","volume":"271","author":"JE Merritt","year":"1990","unstructured":"Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, et al. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J. 1990;271:515\u201322. https:\/\/doi.org\/10.1042\/bj2710515.","journal-title":"Biochem J"},{"key":"766_CR114","doi-asserted-by":"publisher","unstructured":"H\u00e4fner S, Burg F, Kannler M, Urban N, Mayer P, Dietrich A et al. A (+)-Larixol congener with high affinity and subtype selectivity toward TRPC6. ChemMedChem. 2018;13:1028-35. https:\/\/doi.org\/10.1002\/cmdc.201800021","DOI":"10.1002\/cmdc.201800021"},{"key":"766_CR115","doi-asserted-by":"publisher","first-page":"e35393","DOI":"10.1371\/journal.pone.0035393","volume":"7","author":"S Miehe","year":"2012","unstructured":"Miehe S, Crause P, Schmidt T, L\u00f6hn M, Kleemann H-W, Licher T, et al. Inhibition of diacylglycerol-sensitive TRPC channels by synthetic and natural steroids. PLoS ONE. 2012;7:e35393. https:\/\/doi.org\/10.1371\/journal.pone.0035393.","journal-title":"PLoS ONE"},{"key":"766_CR116","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2018.05.041","volume":"432","author":"M Ding","year":"2018","unstructured":"Ding M, Wang H, Qu C, Xu F, Zhu Y, Lv G, et al. Pyrazolo[1,5-a]pyrimidine TRPC6 antagonists for the treatment of gastric cancer. Cancer Lett. 2018;432:47\u201355. https:\/\/doi.org\/10.1016\/j.canlet.2018.05.041.","journal-title":"Cancer Lett"},{"key":"766_CR117","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.kint.2016.09.039","volume":"91","author":"Y-L Wu","year":"2017","unstructured":"Wu Y-L, Xie J, An S-W, Oliver N, Barrezueta NX, Lin M-H, et al. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble Klotho. Kidney Int. 2017;91:830\u201341. https:\/\/doi.org\/10.1016\/j.kint.2016.09.039.","journal-title":"Kidney Int"},{"key":"766_CR118","doi-asserted-by":"publisher","first-page":"1352373","DOI":"10.3389\/fphar.2024.1352373","volume":"15","author":"Y Wei","year":"2024","unstructured":"Wei Y, Li M, Hu Y, Lu J, Wang L, Yin Q, et al. PCC0208057 as a small molecule inhibitor of TRPC6 in the treatment of prostate cancer. Front Pharmacol. 2024;15:1352373. https:\/\/doi.org\/10.3389\/fphar.2024.1352373.","journal-title":"Front Pharmacol"},{"key":"766_CR119","doi-asserted-by":"publisher","unstructured":"Hagmann H, Khayyat NH, Matin M, Oezel C, Chen H, Schauss A, et al. Capsazepine (CPZ) inhibits TRPC6 conductance and is protective in Adriamycin-Induced nephropathy and diabetic glomerulopathy. Cells. 2023;12. https:\/\/doi.org\/10.3390\/cells12020271.","DOI":"10.3390\/cells12020271"},{"key":"766_CR120","doi-asserted-by":"publisher","first-page":"116561","DOI":"10.1016\/j.jep.2023.116561","volume":"313","author":"L Zhou","year":"2023","unstructured":"Zhou L, Wu K, Gao Y, Qiao R, Tang N, Dong D, et al. Piperlonguminine attenuates renal fibrosis by inhibiting TRPC6. J Ethnopharmacol. 2023;313:116561. https:\/\/doi.org\/10.1016\/j.jep.2023.116561.","journal-title":"J Ethnopharmacol"},{"key":"766_CR121","doi-asserted-by":"publisher","first-page":"F1442","DOI":"10.1152\/ajprenal.00212.2013","volume":"306","author":"G Hall","year":"2014","unstructured":"Hall G, Rowell J, Farinelli F, Gbadegesin RA, Lavin P, Wu G, et al. Phosphodiesterase 5 Inhibition ameliorates Angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity. Am J Physiol Ren Physiol. 2014;306:F1442\u201350. https:\/\/doi.org\/10.1152\/ajprenal.00212.2013.","journal-title":"Am J Physiol Ren Physiol"},{"key":"766_CR122","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1681\/ASN.2017020171","volume":"28","author":"NJ Tardi","year":"2017","unstructured":"Tardi NJ, Reiser J. The use of sildenafil for glomerular disease. J Am Soc Nephrol. 2017;28:1329\u201331. https:\/\/doi.org\/10.1681\/ASN.2017020171.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR123","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1681\/ASN.2015050473","volume":"27","author":"W Scheele","year":"2016","unstructured":"Scheele W, Diamond S, Gale J, Clerin V, Tamimi N, Le V, et al. Phosphodiesterase type 5 Inhibition reduces albuminuria in subjects with overt diabetic nephropathy. J Am Soc Nephrol. 2016;27:3459\u201368. https:\/\/doi.org\/10.1681\/ASN.2015050473.","journal-title":"J Am Soc Nephrol"},{"key":"766_CR124","doi-asserted-by":"publisher","unstructured":"\u2019t Hart D, Li J, van der Vlag J, Nijenhuis T. Repurposing Riociguat to target a novel paracrine nitric Oxide-TRPC6 pathway to prevent podocyte injury. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms222212485.","DOI":"10.3390\/ijms222212485"},{"key":"766_CR125","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.ajpath.2011.06.033","volume":"179","author":"T Nijenhuis","year":"2011","unstructured":"Nijenhuis T, Sloan AJ, Hoenderop JGJ, Flesche J, van Goor H, Kistler AD, et al. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol. 2011;179:1719\u201332. https:\/\/doi.org\/10.1016\/j.ajpath.2011.06.033.","journal-title":"Am J Pathol"},{"key":"766_CR126","doi-asserted-by":"crossref","unstructured":"Carver AW, Glenn DA, Westreich KD. RAAS Inhibition delays onset of nephrotic syndrome due to TRPC6-Mediated FSGS: A case report of a sibling pair: TH-PO465. J Am Soc Nephrol 2023;34.","DOI":"10.1681\/ASN.20233411S1219b"},{"key":"766_CR127","doi-asserted-by":"publisher","unstructured":"Feng Y, Li M, Wang Y, Yang M, Shi G, Yin D, et al. Activation of TRPC6 by angII induces podocyte injury and participates in proteinuria of nephrotic syndrome. Front Pharmacol. 2022;13. https:\/\/doi.org\/10.3389\/fphar.2022.915153.","DOI":"10.3389\/fphar.2022.915153"},{"key":"766_CR128","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/HJH.0000000000002326","volume":"38","author":"E Uijl","year":"2020","unstructured":"Uijl E, \u2019t Hart DC, Roksnoer LCW, Groningen MCC, van Veghel R, Garrelds IM, et al. Angiotensin-neprilysin Inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury. J Hypertens. 2020;38:755\u201364. https:\/\/doi.org\/10.1097\/HJH.0000000000002326.","journal-title":"J Hypertens"},{"key":"766_CR129","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.2147\/DMSO.S366518","volume":"15","author":"Y Pan","year":"2022","unstructured":"Pan Y, Liu L, Yang H, Chen W, Chen Z, Xu J. Sacubitril\/Valsartan improves progression of early diabetic nephropathy in rats through Inhibition of NLRP3 inflammasome pathway. Diabetes Metab Syndr Obes. 2022;15:2479\u201388. https:\/\/doi.org\/10.2147\/DMSO.S366518.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"766_CR130","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1172\/JCI27702","volume":"116","author":"K Kuwahara","year":"2006","unstructured":"Kuwahara K, Wang Y, McAnally J, Richardson JA, Bassel-Duby R, Hill JA, et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Invest. 2006;116:3114\u201326. https:\/\/doi.org\/10.1172\/JCI27702.","journal-title":"J Clin Invest"},{"key":"766_CR131","doi-asserted-by":"publisher","first-page":"9810","DOI":"10.1111\/jcmm.15562","volume":"24","author":"S Zhang","year":"2020","unstructured":"Zhang S, Wang H, Liu Y, Yang W, Liu J, Han Y, et al. Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1\/TRPC6 pathway. J Cell Mol Med. 2020;24:9810\u201324. https:\/\/doi.org\/10.1111\/jcmm.15562.","journal-title":"J Cell Mol Med"},{"key":"766_CR132","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/157339911794273973","volume":"7","author":"KN Campbell","year":"2011","unstructured":"Campbell KN, Raij L, Mundel P. Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr Diabetes Rev. 2011;7:3\u20137. https:\/\/doi.org\/10.2174\/157339911794273973.","journal-title":"Curr Diabetes Rev"},{"key":"766_CR133","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neulet.2015.10.052","volume":"610","author":"JE Sexton","year":"2016","unstructured":"Sexton JE, Desmonds T, Quick K, Taylor R, Abramowitz J, Forge A, et al. The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch and hearing. Neurosci Lett. 2016;610:36\u201342. https:\/\/doi.org\/10.1016\/j.neulet.2015.10.052.","journal-title":"Neurosci Lett"},{"key":"766_CR134","doi-asserted-by":"publisher","first-page":"1381479","DOI":"10.3389\/fmed.2024.1381479","volume":"11","author":"Y Liu","year":"2024","unstructured":"Liu Y, Ge R-L, Shan Z-Z, Wang Y-J, Yang Y-Y, Sun X, et al. Adriamycin-induced podocyte injury via the Sema3A\/TRPC5\/Rac1 pathway. Front Med. 2024;11:1381479. https:\/\/doi.org\/10.3389\/fmed.2024.1381479.","journal-title":"Front Med"},{"key":"766_CR135","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/ndt\/gfae025","volume":"39","author":"S Mirioglu","year":"2024","unstructured":"Mirioglu S, Daniel-Fischer L, Berke I, Ahmad SH, Bajema IM, Bruchfeld A, et al. Management of adult patients with podocytopathies: an update from the ERA immunonephrology working group. Nephrol dial transplant off publ Eur dial transpl assoc -. Eur Ren Assoc. 2024;39:569\u201380. https:\/\/doi.org\/10.1093\/ndt\/gfae025.","journal-title":"Eur Ren Assoc"},{"key":"766_CR136","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ceca.2011.08.008","volume":"50","author":"S Chen","year":"2011","unstructured":"Chen S, He F-F, Wang H, Fang Z, Shao N, Tian X-J, et al. Calcium entry via TRPC6 mediates albumin overload-induced Endoplasmic reticulum stress and apoptosis in podocytes. Cell Calcium. 2011;50:523\u20139. https:\/\/doi.org\/10.1016\/j.ceca.2011.08.008.","journal-title":"Cell Calcium"},{"key":"766_CR137","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s10753-023-01808-3","volume":"46","author":"U Saqib","year":"2023","unstructured":"Saqib U, Munjuluri S, Sarkar S, Biswas S, Mukherjee O, Satsangi H, et al. Transient receptor potential canonical 6 (TRPC6) channel in the pathogenesis of diseases: A Jack of many trades. Inflammation. 2023;46:1144\u201360. https:\/\/doi.org\/10.1007\/s10753-023-01808-3.","journal-title":"Inflammation"},{"key":"766_CR138","doi-asserted-by":"publisher","first-page":"36598","DOI":"10.1074\/jbc.M113.488122","volume":"288","author":"AD Kistler","year":"2013","unstructured":"Kistler AD, Singh G, Altintas MM, Yu H, Fernandez IC, Gu C, et al. Transient receptor potential channel 6 (TRPC6) protects podocytes during Complement-mediated glomerular disease**. J Biol Chem. 2013;288:36598\u2013609. https:\/\/doi.org\/10.1074\/jbc.M113.488122.","journal-title":"J Biol Chem"},{"key":"766_CR139","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.2337\/db08-0647","volume":"57","author":"C-H Ku","year":"2008","unstructured":"Ku C-H, White KE, Dei Cas A, Hayward A, Webster Z, Bilous R, et al. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Diabetes. 2008;57:2824\u201333. https:\/\/doi.org\/10.2337\/db08-0647.","journal-title":"Diabetes"},{"key":"766_CR140","doi-asserted-by":"publisher","unstructured":"Asghar MY, T\u00f6rnquist K. Transient receptor potential canonical (TRPC) channels as modulators of migration and invasion. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21051739.","DOI":"10.3390\/ijms21051739"},{"key":"766_CR141","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41392-023-01464-x","volume":"8","author":"M Zhang","year":"2023","unstructured":"Zhang M, Ma Y, Ye X, Zhang N, Pan L, Wang B. TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases. Signal Transduct Target Ther. 2023;8:261. https:\/\/doi.org\/10.1038\/s41392-023-01464-x.","journal-title":"Signal Transduct Target Ther"},{"key":"766_CR142","doi-asserted-by":"publisher","first-page":"103951","DOI":"10.1016\/j.drudis.2024.103951","volume":"29","author":"H Liu","year":"2024","unstructured":"Liu H, Fu M, Zhang Y, You Q, Wang L. Small molecules targeting canonical transient receptor potential channels: an update. Drug Discov Today. 2024;29:103951. https:\/\/doi.org\/10.1016\/j.drudis.2024.103951.","journal-title":"Drug Discov Today"},{"key":"766_CR143","doi-asserted-by":"publisher","first-page":"16586","DOI":"10.1073\/pnas.0606894103","volume":"103","author":"MA Spassova","year":"2006","unstructured":"Spassova MA, Hewavitharana T, Xu W, Soboloff J, Gill DL. A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc Natl Acad Sci U S A. 2006;103:16586\u201391. https:\/\/doi.org\/10.1073\/pnas.0606894103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"766_CR144","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1016\/j.bmcl.2013.06.047","volume":"23","author":"DG Washburn","year":"2013","unstructured":"Washburn DG, Holt DA, Dodson J, McAtee JJ, Terrell LR, Barton L, et al. The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophore. Bioorg Med Chem Lett. 2013;23:4979\u201384. https:\/\/doi.org\/10.1016\/j.bmcl.2013.06.047.","journal-title":"Bioorg Med Chem Lett"},{"key":"766_CR145","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41598-020-57733-0","volume":"10","author":"MA Cozart","year":"2020","unstructured":"Cozart MA, Phelan KD, Wu H, Mu S, Birnbaumer L, Rusch NJ, et al. Vascular smooth muscle TRPC3 channels facilitate the inverse hemodynamic response during status epilepticus. Sci Rep. 2020;10:812. https:\/\/doi.org\/10.1038\/s41598-020-57733-0.","journal-title":"Sci Rep"},{"key":"766_CR146","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ceca.2012.01.001","volume":"51","author":"N Urban","year":"2012","unstructured":"Urban N, Hill K, Wang L, Kuebler WM, Schaefer M. Novel Pharmacological TRPC inhibitors block hypoxia-induced vasoconstriction. Cell Calcium. 2012;51:194\u2013206. https:\/\/doi.org\/10.1016\/j.ceca.2012.01.001.","journal-title":"Cell Calcium"},{"key":"766_CR147","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-94-024-1088-4_9","volume-title":"Transient recept. Potential canonical channels brain dis","author":"Y Tai","year":"2017","unstructured":"Tai Y, Jia Y. TRPC channels and neuron development, plasticity, and activities. In: Wang Y, editor. Transient recept. Potential canonical channels brain dis. Dordrecht: Springer Netherlands; 2017. pp. 95\u2013110. https:\/\/doi.org\/10.1007\/978-94-024-1088-4_9."},{"key":"766_CR148","doi-asserted-by":"publisher","first-page":"2204846","DOI":"10.1002\/advs.202204846","volume":"10","author":"G Rached","year":"2023","unstructured":"Rached G, Saliba Y, Maddah D, Hajal J, Smayra V, Bakhos J-J, et al. TRPC3 regulates islet Beta-Cell insulin secretion. Adv Sci. 2023;10:2204846. https:\/\/doi.org\/10.1002\/advs.202204846.","journal-title":"Adv Sci"},{"key":"766_CR149","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.bbamcr.2015.04.016","volume":"1853","author":"T Smani","year":"2015","unstructured":"Smani T, Shapovalov G, Skryma R, Prevarskaya N, Rosado JA. Functional and physiopathological implications of TRP channels. Biochim Biophys Acta - Mol Cell Res. 2015;1853:1772\u201382. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.04.016.","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"766_CR150","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrneph.2013.109","volume":"9","author":"JH Suh","year":"2013","unstructured":"Suh JH, Miner JH. The glomerular basement membrane as a barrier to albumin. Nat Rev Nephrol. 2013;9:470\u20137. https:\/\/doi.org\/10.1038\/nrneph.2013.109.","journal-title":"Nat Rev Nephrol"},{"key":"766_CR151","doi-asserted-by":"publisher","unstructured":"Sharma G, Sharma AR, Bhattacharya M, Lee S-S, Chakraborty C. CRISPR-Cas9: A preclinical and clinical perspective for the treatment of human diseases. Mol Ther. 2021;29. https:\/\/doi.org\/10.1016\/j.ymthe.2020.09.028.:571\u2013\u200986.","DOI":"10.1016\/j.ymthe.2020.09.028"},{"key":"766_CR152","doi-asserted-by":"publisher","unstructured":"Chai X-N, Ludwig F-A, M\u00fcglitz A, Gong Y, Schaefer M, Regenthal R, et al. A Pharmacokinetic and metabolism study of the TRPC6 inhibitor SH045 in mice by LC-MS\/MS. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23073635.","DOI":"10.3390\/ijms23073635"},{"key":"766_CR153","doi-asserted-by":"publisher","unstructured":"van Asbeck AH, Dieker J, Boswinkel M, van der Vlag J, Brock R. Kidney-targeted therapies: A quantitative perspective. J Control Release. 2020;328. https:\/\/doi.org\/10.1016\/j.jconrel.2020.09.022. https:\/\/doi.org\/https:\/\/doi.org\/.:762\u2013\u200975.","DOI":"10.1016\/j.jconrel.2020.09.022"},{"key":"766_CR154","doi-asserted-by":"publisher","first-page":"C558","DOI":"10.1152\/ajpcell.00077.2008","volume":"296","author":"J Schl\u00f6ndorff","year":"2009","unstructured":"Schl\u00f6ndorff J, Del Camino D, Carrasquillo R, Lacey V, Pollak MR. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am J Physiol Cell Physiol. 2009;296:C558\u201369. https:\/\/doi.org\/10.1152\/ajpcell.00077.2008.","journal-title":"Am J Physiol Cell Physiol"},{"key":"766_CR155","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.kint.2018.10.027","volume":"95","author":"A Staruschenko","year":"2019","unstructured":"Staruschenko A. TRPC6 in diabetic kidney disease: good guy or bad guy? Kidney Int. 2019;95:256\u20138. https:\/\/doi.org\/10.1016\/j.kint.2018.10.027.","journal-title":"Kidney Int"},{"key":"766_CR156","doi-asserted-by":"publisher","unstructured":"Mukerji N, Damodaran TV, Winn MP. TRPC6 and FSGS: the latest TRP channelopathy. Biochim Biophys Acta - Mol Basis Dis. 2007;1772. https:\/\/doi.org\/10.1016\/j.bbadis.2007.03.005. https:\/\/doi.org\/https:\/\/doi.org\/.:859\u2013\u200968.","DOI":"10.1016\/j.bbadis.2007.03.005"},{"key":"766_CR157","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/jnci\/djp477","volume":"102","author":"B Freidlin","year":"2010","unstructured":"Freidlin B, McShane LM, Korn EL. Randomized clinical trials with biomarkers: design issues. J Natl Cancer Inst. 2010;102:152\u201360. https:\/\/doi.org\/10.1093\/jnci\/djp477.","journal-title":"J Natl Cancer Inst"},{"key":"766_CR158","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/978-3-319-05161-1_10","volume":"223","author":"UA Hellmich","year":"2014","unstructured":"Hellmich UA, Gaudet R. Structural biology of TRP channels. Handb Exp Pharmacol. 2014;223:963\u201390. https:\/\/doi.org\/10.1007\/978-3-319-05161-1_10.","journal-title":"Handb Exp Pharmacol"},{"key":"766_CR159","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ceca.2018.12.009","volume":"78","author":"S H\u00e4fner","year":"2019","unstructured":"H\u00e4fner S, Urban N, Schaefer M. Discovery and characterization of a positive allosteric modulator of transient receptor potential canonical 6 (TRPC6) channels. Cell Calcium. 2019;78:26\u201334. https:\/\/doi.org\/10.1016\/j.ceca.2018.12.009.","journal-title":"Cell Calcium"},{"key":"766_CR160","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1177\/1087057114560698","volume":"20","author":"TCI Wilkinson","year":"2015","unstructured":"Wilkinson TCI, Gardener MJ, Williams WA. Discovery of functional antibodies targeting ion channels. SLAS Discov. 2015;20:454\u201367. https:\/\/doi.org\/10.1177\/1087057114560698. https:\/\/doi.org\/https:\/\/.","journal-title":"SLAS Discov"},{"key":"766_CR161","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/19420862.2018.1548232","volume":"11","author":"CJ Hutchings","year":"2019","unstructured":"Hutchings CJ, Paul C, Clark TG. Ion channels as therapeutic antibody targets. MAbs. 2019;11:265\u201396. https:\/\/doi.org\/10.1080\/19420862.2018.1548232.","journal-title":"MAbs"},{"key":"766_CR162","doi-asserted-by":"publisher","first-page":"101800","DOI":"10.1016\/j.xcrm.2024.101800","volume":"5","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ding Y, Zeng Z, Zhu R, Zheng P, Fan S, et al. Intra-channel bi-epitopic crosslinking unleashes ultrapotent antibodies targeting NaV1.7 for pain alleviation. Cell Rep Med. 2024;5:101800. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101800.","journal-title":"Cell Rep Med"},{"key":"766_CR163","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/wnl.54.2.474","volume":"54","author":"K Jahn","year":"2000","unstructured":"Jahn K, Franke C, Bufler J. Mechanism of block of nicotinic acetylcholine receptor channels by purified IgG from seropositive patients with myasthenia Gravis. Neurology. 2000;54:474\u20139. https:\/\/doi.org\/10.1212\/wnl.54.2.474.","journal-title":"Neurology"},{"key":"766_CR164","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa1110740","volume":"367","author":"R Srivastava","year":"2012","unstructured":"Srivastava R, Aslam M, Kalluri SR, Schirmer L, Buck D, Tackenberg B, et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med. 2012;367:115\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1110740.","journal-title":"N Engl J Med"},{"key":"766_CR165","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.expneurol.2014.06.002","volume":"261","author":"SB Park","year":"2014","unstructured":"Park SB, Lin CS-Y, Krishnan AV, Simon NG, Bostock H, Vincent A, et al. Axonal dysfunction with voltage gated potassium channel complex antibodies. Exp Neurol. 2014;261:337\u201342. https:\/\/doi.org\/10.1016\/j.expneurol.2014.06.002.","journal-title":"Exp Neurol"},{"key":"766_CR166","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1523\/JNEUROSCI.6007-10.2011","volume":"31","author":"A Dhingra","year":"2011","unstructured":"Dhingra A, Fina ME, Neinstein A, Ramsey DJ, Xu Y, Fishman GA, et al. Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells. J Neurosci Off J Soc Neurosci. 2011;31:3962\u20137. https:\/\/doi.org\/10.1523\/JNEUROSCI.6007-10.2011.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"766_CR167","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/157340011797183184","volume":"7","author":"MS Kayser","year":"2011","unstructured":"Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis in psychiatry. Curr Psychiatry Rev. 2011;7:189\u201393. https:\/\/doi.org\/10.2174\/157340011797183184.","journal-title":"Curr Psychiatry Rev"},{"key":"766_CR168","first-page":"339","volume":"62","author":"T Misawa","year":"2010","unstructured":"Misawa T, Mizusawa H. [Anti-VGKC antibody-associated limbic encephalitis\/morvan syndrome]. Brain Nerve. 2010;62:339\u201345.","journal-title":"Brain Nerve"},{"key":"766_CR169","doi-asserted-by":"publisher","first-page":"10339","DOI":"10.1038\/ncomms10339","volume":"7","author":"H Sun","year":"2016","unstructured":"Sun H, Luo L, Lal B, Ma X, Chen L, Hann CL, et al. A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis. Nat Commun. 2016;7:10339. https:\/\/doi.org\/10.1038\/ncomms10339.","journal-title":"Nat Commun"},{"key":"766_CR170","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00109-018-1648-3","volume":"96","author":"EY Kim","year":"2018","unstructured":"Kim EY, Yazdizadeh Shotorbani P, Dryer SE. Trpc6 inactivation confers protection in a model of severe nephrosis in rats. J Mol Med (Berl). 2018;96:631\u201344. https:\/\/doi.org\/10.1007\/s00109-018-1648-3.","journal-title":"J Mol Med (Berl)"},{"key":"766_CR171","doi-asserted-by":"publisher","first-page":"sfae119","DOI":"10.1093\/ckj\/sfae119","volume":"17","author":"N Tavakolidakhrabadi","year":"2024","unstructured":"Tavakolidakhrabadi N, Aulicino F, May CJ, Saleem MA, Berger I, Welsh GI. Genome editing and kidney health. Clin Kidney J. 2024;17:sfae119. https:\/\/doi.org\/10.1093\/ckj\/sfae119.","journal-title":"Clin Kidney J"},{"key":"766_CR172","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s00018-020-03739-w","volume":"78","author":"R Vitorino","year":"2021","unstructured":"Vitorino R, Ferreira R, Guedes S, Amado F, Thongboonkerd V. What can urinary exosomes tell us? Cell Mol Life Sci. 2021;78:3265\u201383. https:\/\/doi.org\/10.1007\/s00018-020-03739-w.","journal-title":"Cell Mol Life Sci"},{"key":"766_CR173","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/ndt\/gfw077","volume":"32","author":"SH Kwon","year":"2017","unstructured":"Kwon SH, Woollard JR, Saad A, Garovic VD, Zand L, Jordan KL, et al. Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients. Nephrol dial transplant off publ Eur dial transpl assoc Eur Ren Assoc. 2017;32:800\u20137. https:\/\/doi.org\/10.1093\/ndt\/gfw077.","journal-title":"Eur Ren Assoc"},{"key":"766_CR174","doi-asserted-by":"publisher","first-page":"113055","DOI":"10.1016\/j.biopha.2022.113055","volume":"150","author":"X Li","year":"2022","unstructured":"Li X, Yang L. Urinary exosomes: emerging therapy delivery tools and biomarkers for urinary system diseases. Biomed Pharmacother. 2022;150:113055. https:\/\/doi.org\/10.1016\/j.biopha.2022.113055.","journal-title":"Biomed Pharmacother"},{"key":"766_CR175","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1172\/JCI81061","volume":"125","author":"J Wu","year":"2015","unstructured":"Wu J, Zheng C, Wang X, Yun S, Zhao Y, Liu L, et al. MicroRNA-30 family members regulate calcium\/calcineurin signaling in podocytes. J Clin Invest. 2015;125:4091\u2013106. https:\/\/doi.org\/10.1172\/JCI81061.","journal-title":"J Clin Invest"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00766-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00766-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00766-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:08:04Z","timestamp":1768342084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00766-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":175,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00766-x","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics, consent to participate, and consent to publish"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}